Your browser doesn't support javascript.
loading
Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis.
Fallahzadeh, Mohammad Amin; Asrani, Sumeet K; Tapper, Elliot B; Saracino, Giovanna; Rahimi, Robert S.
Afiliación
  • Fallahzadeh MA; Department of Internal Medicine, Baylor University Medical Center, Dallas, TX 75246, United States. aminfa91@gmail.com.
  • Asrani SK; Division of Hepatology, Baylor University Medical Center, Dallas, TX 75246, United States.
  • Tapper EB; Division of Hepatology, University of Michigan, Ann Arbor, MI 48109, United States.
  • Saracino G; Division of Hepatology, Baylor University Medical Center, Dallas, TX 75246, United States.
  • Rahimi RS; Division of Hepatology, Baylor University Medical Center, Dallas, TX 75246, United States.
World J Clin Cases ; 10(23): 8097-8106, 2022 Aug 16.
Article en En | MEDLINE | ID: mdl-36159543

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: World J Clin Cases Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: World J Clin Cases Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos